<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02955407</url>
  </required_header>
  <id_info>
    <org_study_id>2016-00647</org_study_id>
    <nct_id>NCT02955407</nct_id>
  </id_info>
  <brief_title>Genetic Predisposition for Chronic Non-specific Low Back Pain</brief_title>
  <acronym>Backgene</acronym>
  <official_title>Genetic Predisposition for Reduced Back Muscle Strength and Back Muscle Endurance in Patients With Chronic Non-specific Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balgrist University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balgrist University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with inflammatory back pain were shown to differ from healthy controls in genotype
      of the Angiotensin-converting enzyme (ACE), which regulates vasoconstriction/-dilatation. The
      aim of this study is to investigate whether genetic reduction of muscle perfusion might be a
      pathophysiological pathway of how genes influence chronic non-specific low back pain (LBP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The following genes will be investigated:

        -  Insertions-/deletions-polymorphism of the angiotensin-converting enzyme (ACE-I/D gene
           polymorphism; 3 genotypes: ACE-II, ACE-ID, ACE-DD).

        -  Anti-adhesive extracellular matrix protein Tenascin-C: gene polymorphism rs2104772

      The goals of this study are to investigate whether these genotypes correlate with 1)
      endurance of back muscles, 2) comorbidities such as asthma and diabetes and 3) the risk for
      LBP as assessed by a LBP-classification tool.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">August 31, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Polymorphism ACE Gene</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Polymorphism Tenascin Gene</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Back muscle endurance in Sorensen test</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Low back pain patients</arm_group_label>
    <description>Low back pain since more than 3 months Age: 18-65 Caucasian race</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls without low back pain</arm_group_label>
    <description>no low back ain Age: 18-65 Caucasian race</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>observational case-control study</description>
    <arm_group_label>Controls without low back pain</arm_group_label>
    <arm_group_label>Low back pain patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic low back pain and healthy controls without low back pain.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65

        Exclusion Criteria:

          -  Spinal surgery

          -  Spinal fracture

          -  Inflammation

          -  Tumour

          -  Severe chronic disease which make intensive physical activity impossible
             (osteoporosis, cardiovascular heart diseases)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Flück, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Balgrist University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Balgrist University Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Vaughan D, Huber-Abel FA, Graber F, Hoppeler H, Flück M. The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise. Eur J Appl Physiol. 2013 Jul;113(7):1719-29. doi: 10.1007/s00421-012-2583-6. Epub 2013 Feb 9.</citation>
    <PMID>23397151</PMID>
  </reference>
  <reference>
    <citation>Shehab DK, Al-Jarallah KF, Al-Awadhi AM, Al-Herz A, Nahar I, Haider MZ. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies. J Biomed Sci. 2008 Jan;15(1):61-7. Epub 2007 Aug 23.</citation>
    <PMID>17713861</PMID>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>October 6, 2016</study_first_submitted>
  <study_first_submitted_qc>November 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2016</study_first_posted>
  <last_update_submitted>January 22, 2019</last_update_submitted>
  <last_update_submitted_qc>January 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

